Berman Tabacco Announces Investigation of SelectQuote, Inc. (NYSE:SLQT) — Neutral

SLQT   GlobeNewsWire — December 02, 2025

BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving SelectQuote, Inc. (“SelectQuote”) (NYSE:SLQT) allegedly receiving illegal payments from health insurance providers.

image for news Berman Tabacco Announces Investigation of SelectQuote, Inc. (NYSE:SLQT)

NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the “Class Period”), of the important December 15, 2025 lead plaintiff deadline.

image for news MLTX FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action – MLTX

Nutex Health Inc. (NUTX) Discusses Restated 2024 Results and Combined Second and Third Quarter 2025 Financial Performance Transcript

image for news Nutex Health Inc. (NUTX) Discusses Restated 2024 Results and Combined Second and Third Quarter 2025 Financial Performance Transcript

Third Coast Bancshares Is Undervalued And Worth Banking On — Positive

TCBX   Seeking Alpha — December 02, 2025

Third Coast Bancshares remains a "Buy," supported by strong asset quality, attractive valuation, and robust balance sheet growth. TCBX's net interest margin rose to 4.05%, driving net profits up to $44.8 million and returns well above industry minimums. The announced $123 million Keystone Bancshares merger expands Texas presence, especially in Austin, with potential cost synergies and scale benefits.

image for news Third Coast Bancshares Is Undervalued And Worth Banking On

Signet Jewelers said lab-grown diamonds made up 40% of its bridal business, up from a mid-30s percentage six months ago.

image for news Getting engaged? There's a rising chance your ring will have a lab-grown diamond.

Taseko Mines Limited (TKO:CA) Presents at Bank of America Leveraged Finance Conference Transcript

image for news Taseko Mines Limited (TKO:CA) Presents at Bank of America Leveraged Finance Conference Transcript

Global Payments Inc. (GPN) Presents at UBS Global Technology and AI Conference 2025 Transcript

image for news Global Payments Inc. (GPN) Presents at UBS Global Technology and AI Conference 2025 Transcript

The Clorox Company (CLX) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript

image for news The Clorox Company (CLX) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript

The Coca-Cola Company (KO) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript

image for news The Coca-Cola Company (KO) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript

Biogen Inc. (BIIB) Presents at Evercore 8th Annual Healthcare Conference Transcript

image for news Biogen Inc. (BIIB) Presents at Evercore 8th Annual Healthcare Conference Transcript

Halozyme Therapeutics, Inc. (HALO) Presents at Evercore 8th Annual Healthcare Conference Transcript

image for news Halozyme Therapeutics, Inc. (HALO) Presents at Evercore 8th Annual Healthcare Conference Transcript

Credo Technologies Posted a Blowout Quarter—Here's What's Next — Positive

CRDO   MarketBeat — December 02, 2025

Credo Technologies' NASDAQ: CRDO fiscal year 2026 (FY2026) Q2 results are yet another example of why the AI trade is far from over. As NVIDIA NASDAQ: NVDA and Advanced Micro Devices NASDAQ: AMD continue to dominate GPU sales for AI data centers built by Microsoft NASDAQ: MSFT, Amazon NASDAQ: AMZN, and Meta Platforms NASDAQ: META, the demand for high-speed connectivity grows in parallel.

image for news Credo Technologies Posted a Blowout Quarter—Here's What's Next

Novo Nordisk in 2020 launched pivotal trials of its GLP-1 drug semaglutide in Alzheimer's patients based on studies in humans, animals and real-world findings, a top company executive said on Tuesday, acknowledging criticism that Novo's studies had design flaws.

image for news Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials

Microsoft Corporation (NASDAQ: MSFT) is among the companies that are investing heavily in data centers for AI growth. The company's CEO has a warning for the increased energy needed for the AI sector and for fears of an AI bubble.

image for news Microsoft CEO Says AI Sector Needs Multiple Winners: 'Otherwise It'll Be A Road To Nowhere'

SAN DIEGO , Dec. 2, 2025 /PRNewswire/ -- Company: Skye Bioscience, Inc. (NYSE: SKYE) is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors ("GPCRs") to treat obesity, overweight, and metabolic diseases. The Company's lead product candidate is nimacimab.

image for news SKYE Class Action Reminder: Skye Bioscience, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit

Aramark: Near-Term Growth Outlook Remains Uncertain — Negative

ARMK   Seeking Alpha — December 02, 2025

Aramark remains a Hold as the near-term FY26 outlook is unattractive despite strong commercial momentum and major contract wins. Q4 2025 revenue growth was inflated by a 53rd week, and underlying organic growth and profitability missed expectations, with adj. EBIT margin disappointing. ARMK's record new business wins, especially in healthcare, validate its competitiveness, but onboarding and timing risks threaten revenue recognition and earnings flow-through.

image for news Aramark: Near-Term Growth Outlook Remains Uncertain

New York, New York--(Newsfile Corp. - December 2, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primo Water Corporation (NYSE: PRMW) between June 17, 2024 and November 8, 2024, both dates inclusive, and/or (ii) purchasers of common stock of Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 and November 6, 2025 (the "Class Period"), of the important January 12, 2026 lead plaintiff deadline. SO WHAT: If you purchased Primo Brands securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees …

image for news ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Primo Brands Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRMB, PRMW

SAN DIEGO , Dec. 2, 2025 /PRNewswire/ -- Company: Primo Brands Corporation (NYSE: PRMB) purports to be a leading North American branded beverage company focused on healthy hydration, offering responsibly sourced products across multiple formats, channels, and price points, and for a wide range of consumer occasions. Its products are distributed in every U.S. state and in Canada.

image for news PRMB Class Action Reminder: Primo Brands Corporation Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit

Zscaler, Inc. ( ZS ) UBS Global Technology and AI Conference 2025 December 2, 2025 12:15 PM EST Company Participants Jagtar Chaudhry - Co-Founder, CEO & Chairman of the Board Conference Call Participants Roger Boyd - UBS Investment Bank, Research Division Presentation Roger Boyd UBS Investment Bank, Research Division All right. We will get going here.

image for news Zscaler, Inc. (ZS) Presents at UBS Global Technology and AI Conference 2025 Transcript

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

image for news Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript